chr3-134559409-C-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001353108.3(CEP63):c.1933C>G(p.Gln645Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000508 in 1,613,446 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001353108.3 missense
Scores
Clinical Significance
Conservation
Publications
- Seckel syndrome 6Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEP63 | NM_001353108.3 | c.1933C>G | p.Gln645Glu | missense_variant | Exon 14 of 15 | ENST00000675561.1 | NP_001340037.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152158Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000837 AC: 21AN: 250846 AF XY: 0.0000959 show subpopulations
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461288Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 726986 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152158Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74324 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 210703). This variant has not been reported in the literature in individuals affected with CEP63-related conditions. This variant is present in population databases (rs200642598, gnomAD 0.03%). This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 645 of the CEP63 protein (p.Gln645Glu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.1933C>G (p.Q645E) alteration is located in exon 15 (coding exon 13) of the CEP63 gene. This alteration results from a C to G substitution at nucleotide position 1933, causing the glutamine (Q) at amino acid position 645 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at